17Apr 2025
Linezolid Dosing in Hepatic and Renal Impairment

Linezolid Dosing in Hepatic and Renal Impairment

The study found that hepatic impairment reduces linezolid metabolism, increasing drug exposure. Renal failure further elevates linezolid and metabolite levels via reduced metabolism and filtration. No tissue accumulation or transporter-mediated effects were observed. These results underscore the need to adjust linezolid dosing in patients with liver or kidney dysfunction.

  • #oncology
  • #pharmacology

Like

Save

Share